143 related articles for article (PubMed ID: 18847451)
1. Aberrant promoter CpG island hypermethylation of the adenomatosis polyposis coli gene can serve as a good prognostic factor by affecting lymph node metastasis in squamous cell carcinoma of the esophagus.
Kim YT; Park JY; Jeon YK; Park SJ; Song JY; Kang CH; Sung SW; Kim JH
Dis Esophagus; 2009; 22(2):143-50. PubMed ID: 18847451
[TBL] [Abstract][Full Text] [Related]
2. [Hypermethylation of promoter region of RAS association domain family gene1A in esophageal squamous cell carcinoma and significance thereof].
Cong DG; Wang SF
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2932-4. PubMed ID: 18261310
[TBL] [Abstract][Full Text] [Related]
3. [Correlation of aberrant methylation of MGMT gene to MTHFR C677T genetic polymorphisms in esophageal squamous cell carcinoma].
Xue HC; Wang JM; Xu B; Guo GP; Hua ZL; Zhou Q; Zhu ZH; Ma ZK; Gao J
Ai Zheng; 2008 Dec; 27(12):1256-62. PubMed ID: 19079989
[TBL] [Abstract][Full Text] [Related]
4. Methylation of RASSF1A gene promoter and the correlation with DNMT1 expression that may contribute to esophageal squamous cell carcinoma.
Du Z; Ma K; Sun X; Li A; Wang H; Zhang L; Lin F; Feng X; Song J
World J Surg Oncol; 2015 Apr; 13():141. PubMed ID: 25886188
[TBL] [Abstract][Full Text] [Related]
5. Aberrant DNA methylation of P16, MGMT, and hMLH1 genes in combination with MTHFR C677T genetic polymorphism in esophageal squamous cell carcinoma.
Wang J; Sasco AJ; Fu C; Xue H; Guo G; Hua Z; Zhou Q; Jiang Q; Xu B
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):118-25. PubMed ID: 18199718
[TBL] [Abstract][Full Text] [Related]
6. Qualitative analysis of Adenomatous Polyposis Coli promoter: hypermethylation, engagement and effects on survival of patients with esophageal cancer in a high risk region of the world, a potential molecular marker.
Zare M; Jazii FR; Alivand MR; Nasseri NK; Malekzadeh R; Yazdanbod M
BMC Cancer; 2009 Jan; 9():24. PubMed ID: 19149902
[TBL] [Abstract][Full Text] [Related]
7. Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival.
Brabender J; Usadel H; Danenberg KD; Metzger R; Schneider PM; Lord RV; Wickramasinghe K; Lum CE; Park J; Salonga D; Singer J; Sidransky D; Hölscher AH; Meltzer SJ; Danenberg PV
Oncogene; 2001 Jun; 20(27):3528-32. PubMed ID: 11429699
[TBL] [Abstract][Full Text] [Related]
8. Prognostic implication of aberrant promoter hypermethylation of CpG islands in adenocarcinoma of the lung.
Kim YT; Park SJ; Lee SH; Kang HJ; Hahn S; Kang CH; Sung SW; Kim JH
J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1378. PubMed ID: 16256792
[TBL] [Abstract][Full Text] [Related]
9. Methylation of the promoter of human leukocyte antigen class I in human esophageal squamous cell carcinoma and its histopathological characteristics.
Qifeng S; Bo C; Xingtao J; Chuanliang P; Xiaogang Z
J Thorac Cardiovasc Surg; 2011 Mar; 141(3):808-14. PubMed ID: 21335133
[TBL] [Abstract][Full Text] [Related]
10. FHIT expression and hypermethylation in esophageal squamous cell carcinoma.
Noguchi T; Takeno S; Kimura Y; Uchida Y; Daa T; Yokoyama S; Gabbert HE; Mueller W
Int J Mol Med; 2003 Apr; 11(4):441-7. PubMed ID: 12632095
[TBL] [Abstract][Full Text] [Related]
11. [Promoter hypermethylation and loss of heterozygosity of the APC gene in patients with familial adenomatous polyposis].
Zhang YY; Chen SQ; Zhu M; Li JT; Ma GJ; Zhang XM; Zhou JN
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):378-81. PubMed ID: 18683131
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylation-modulated downregulation of RASSF1A expression is associated with the progression of esophageal cancer.
Mao WM; Li P; Zheng QQ; Wang CC; Ge MH; Hu FJ; Fang XH; Dong ZM; Ling ZQ
Arch Med Res; 2011 Apr; 42(3):182-8. PubMed ID: 21722812
[TBL] [Abstract][Full Text] [Related]
13. Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients.
Harden SV; Tokumaru Y; Westra WH; Goodman S; Ahrendt SA; Yang SC; Sidransky D
Clin Cancer Res; 2003 Apr; 9(4):1370-5. PubMed ID: 12684406
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of DNA methylation markers to predict lymph node metastasis of esophageal squamous cell carcinomas.
Gyobu K; Yamashita S; Matsuda Y; Igaki H; Niwa T; Oka D; Kushima R; Osugi H; Lee S; Suehiro S; Ushijima T
Ann Surg Oncol; 2011 Apr; 18(4):1185-94. PubMed ID: 21042947
[TBL] [Abstract][Full Text] [Related]
15. Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma.
Eads CA; Lord RV; Kurumboor SK; Wickramasinghe K; Skinner ML; Long TI; Peters JH; DeMeester TR; Danenberg KD; Danenberg PV; Laird PW; Skinner KA
Cancer Res; 2000 Sep; 60(18):5021-6. PubMed ID: 11016622
[TBL] [Abstract][Full Text] [Related]
16. Can aberrant promoter hypermethylation of CpG islands predict the clinical outcome of non-small cell lung cancer after curative resection?
Kim YT; Lee SH; Sung SW; Kim JH
Ann Thorac Surg; 2005 Apr; 79(4):1180-8; discussion 1180-8. PubMed ID: 15797047
[TBL] [Abstract][Full Text] [Related]
17. Loss of E-cadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance.
Chang HW; Chow V; Lam KY; Wei WI; Yuen A
Cancer; 2002 Jan; 94(2):386-92. PubMed ID: 11900224
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide hypomethylation and specific tumor-related gene hypermethylation are associated with esophageal squamous cell carcinoma outcome.
Hoshimoto S; Takeuchi H; Ono S; Sim MS; Huynh JL; Huang SK; Marzese DM; Kitagawa Y; Hoon DS
J Thorac Oncol; 2015 Mar; 10(3):509-17. PubMed ID: 25514805
[TBL] [Abstract][Full Text] [Related]
19. Promoter methylation of APC and RAR-β genes as prognostic markers in non-small cell lung cancer (NSCLC).
Feng H; Zhang Z; Qing X; Wang X; Liang C; Liu D
Exp Mol Pathol; 2016 Feb; 100(1):109-13. PubMed ID: 26681652
[TBL] [Abstract][Full Text] [Related]
20. Molecular detection of p16 promoter methylation in the serum of patients with esophageal squamous cell carcinoma.
Hibi K; Taguchi M; Nakayama H; Takase T; Kasai Y; Ito K; Akiyama S; Nakao A
Clin Cancer Res; 2001 Oct; 7(10):3135-8. PubMed ID: 11595706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]